ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

39

P1343 Toll Interacting Protein (TOLLIP) Gene

P1359 Sputum Levels of Extracellular DNA Are Increased in Rheumatoid Arthritis-associated Interstitial Lung Disease and Correlate With Sputum Levels of Transforming Growth Factor-ß P1360 A Multinational Phase 2, Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study to Evaluate the Safety and Efficacy of FP-045, An Aldehyde Dehydrogenase 2 Activator in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease P1361 Sting Regulates the Progression of Pulmonary Fibrosis Via Glut1-dependent Glycolysis A33 PUSHING THE IMMUNE SYSTEM TO THE LIMIT: CASE STUDIES 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P359 Common Variable Immunodeficiency: Experience of a Respiratory Service P360 Reporting a Case of Common Variable Immunodeficiency Presenting as Bronchiectasis P361 Unmasking Common Variable Immunodeficiency (CVID) Presenting as Asymptomatic Fluctuating Pulmonary Nodules: A Case Report P362 Aseptic Meningitis Unmasking a Diagnosis Common Variable Immunodeficiency (CVID) and Granulomatous Interstitial Lung Disease P363 A Landscaper’s Worst Nightmare P364 A Case of Delayed Pleuropericarditis After Bilateral Lung Transplantation P365 Immune Cell Recovery in an Adult CGD Patient After T Cell Depleted Vertebral Bone Marrow Transplant (BMT) Following Bilateral Orthotopic Lung Transplant (BOLT) From the Same Partially HLA-matched Cadaveric Donor San Diego Convention Center Area D (Hall A-B2, Ground Level) BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

Polymorphisms in Patients With Systemic Sclerosis (SSc) With and Without Interstitial Lung Disease (ILD): Association With Outcome and Survival

P1344 Murine Multiple Challenge Bleomycin-Induced Model of Lung Fibrosis Features Elements of Human Idiopathic Pulmonary Fibrosis and Is Reverted by Nintedanib Treatment P1345 Microbiome Features in Bronchoalveolar Lavage Fluid of Patients With Idiopathic Inflammatory Myopathy Related Interstitial Lung Disease P1346 Differential Upregulation of Interferon-induced Genes in Monocytes of Connective Tissue Disease-related Interstitial Lung Disease P1347 Identifying a Genetic Link Between Lung Function and Psoriasis P1349 Dental Dyspnea Among Prosthodontists Is Associated With Amalgam Inhalation P1350 Studying How Aging Related Macrophage Changes in Transcriptional Regulatory Networks Drive Pulmonary Fibrosis P1351 Preclinical Interleukin Profile of RSBT-001: A First-in-Class, Steroid-free Immune Modulator in Development for Idiopathic Pulmonary Fibrosis P1352 Altered NKT Cell Populations in the Airways of Patients With IPF P1353 Evaluation of Fibrotic RNA-seq Signature Profile in a PPAR-Y Deficient Murine Model of Fibrosis P1354 Predictors of Mortality in Idiopathic Pulmonary Fibrosis: Forced Vital Capacity Decline and Other Surrogate Endpoints - A Literature Review P1355 Gut Microbiota Induce Pulmonary IL-6 Expression Through HIF-1 a Signaling in Murine ILD Models P1356 Effects of Antifibrotic Drugs on Transcriptome Analysis of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis P1357 Time-course of Eosinophilia Attenuated by Systemic Corticosteroid in Chronic Eosinophilic Pneumonia P1358 Quantitative Computed Tomography Predicts Outcomes in Fibrotic Hypersensitivity Pneumonitis

ATS 2024 Conference Program • San Diego, CA